menu ☰
menu ˟

Novel flu vaccine shows efficacy against mismatched H3N2 virus

21 Mar 2019
Preliminary phase 2 data from a controlled human infection trial showed that an investigational influenza vaccine being developed by FluGen was protective against a substantially mismatched influenza A(H3N2) virus, the company announced.The vaccine, ...

Click here to view the full article which appeared in Nursing

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.